Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJK3S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,706
Award facts
- Contract value 100% obligated
- $32,706.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32.7K delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on January 27, 2026, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Wegovy is a GLP-1 receptor agonist used primarily for weight management in adults with obesity or overweight conditions, representing part of the federal government's pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen, as a major pharmaceutical distributor, has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition and serves as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJK3S?
SPE2DR26FJK3S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FJK3S worth?
The government has obligated $32,706 on SPE2DR26FJK3S.
Is contract SPE2DR26FJK3S an order under another contract?
Yes. SPE2DR26FJK3S is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK3S competed?
The extent of competition for SPE2DR26FJK3S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award